Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
University of Pennsylvania · with National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · NCT05865054
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 50+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 400
- US sites recruiting
- 2
- Study start
- July 29, 2020
- Record last updated
- September 25, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).
Being studied: Magnetic Resonance Imaging (MRI)
Conditions: Giant Cell Arteritis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 50 years or older
- First presentation of suspected GCA
- New or worsening cranial manifestations within 4 weeks of enrollment concerning for active GCA
- Elevated CRP greater than 1.0 mg/dl
- Plan to undergo temporal artery biopsy or ultrasound for diagnosis
Exclusion Criteria
- Contra-indication to receiving MRI including:
Implanted medical devices, pacemaker, and metallic foreign fragments inside body/orbits Known gadolinium allergy Women who are pregnant or nursing
- Absence of cranial symptoms related to GCA (e.g., only large vessel GCA)
Recruiting US locations
Mayo Building and Gonda Building
Rochester, MN 55905
Site contact: Jennifer Sletten · 507-284-3695 · sletten.jennifer@mayo.edu
3400 Civic Center Blvd
Philadelphia, PA 19104
Site contact: Brenda Hernandez-Romero, B.S · 917-548-2067 · Brenda_Hernandez-Romero@pennmedicine.upenn.edu
Study contacts (from the official record)
- Brenda Hernandez-Romero, B.S · 917-548-2067 · Brenda_Hernandez-Romero@pennmedicine.upenn.edu
Similar studies in Minnesota
All healthy volunteers studies in Minnesota →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Rochester, MN + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
- Location
- Dilworth, MN + 2 other US sites
- Eligibility basics
- Ages 25–75
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–75